...
首页> 外文期刊>Journal of Hematology and Oncology >RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
【24h】

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential

机译:RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential

获取原文
获取原文并翻译 | 示例
           

摘要

RNA demethylase ALKBH5 takes part in the modulation of N-6-methyladenosine (m(6)A) modification and controls various cell processes. ALKBH5-mediated m(6)A demethylation regulates gene expression by affecting multiple events in RNA metabolism, e.g., pre-mRNA processing, mRNA decay and translation. Mounting evidence shows that ALKBH5 plays critical roles in a variety of human malignancies, mostly via post-transcriptional regulation of oncogenes or tumor suppressors in an m(6)A-dependent manner. Meanwhile, increasing non-coding RNAs are recognized as functional targets of ALKBH5 in cancers. Here we reviewed up-to-date findings about the pathological roles of ALKBH5 in cancer, the molecular mechanisms by which it exerts its functions, as well as the underlying mechanism of its dysregulation. We also discussed the therapeutic implications of targeting ALKBH5 in cancer and potential ALKBH5-targeting strategies.
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号